441 related articles for article (PubMed ID: 32829384)
1. Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation.
Tan J; Liu H; Huang M; Li N; Tang S; Meng J; Tang S; Zhou H; Kijlstra A; Yang P; Hou S
Cell Death Dis; 2020 Aug; 11(8):697. PubMed ID: 32829384
[TBL] [Abstract][Full Text] [Related]
2. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.
Lee K; Hwang S; Paik DJ; Kim WK; Kim JM; Youn J
Clin Exp Immunol; 2012 Oct; 170(1):66-76. PubMed ID: 22943202
[TBL] [Abstract][Full Text] [Related]
3. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
[TBL] [Abstract][Full Text] [Related]
4. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
5. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
[TBL] [Abstract][Full Text] [Related]
6. SOX-5 activates a novel RORγt enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation.
Tian Y; Han C; Wei Z; Dong H; Shen X; Cui Y; Fu X; Tian Z; Wang S; Zhou J; Yang D; Sun Y; Yuan J; Ni B; Wu Y
Nat Commun; 2021 Jan; 12(1):481. PubMed ID: 33473108
[TBL] [Abstract][Full Text] [Related]
7. Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
Tanaka S; Suto A; Iwamoto T; Kashiwakuma D; Kagami S; Suzuki K; Takatori H; Tamachi T; Hirose K; Onodera A; Suzuki J; Ohara O; Yamashita M; Nakayama T; Nakajima H
J Exp Med; 2014 Aug; 211(9):1857-74. PubMed ID: 25073789
[TBL] [Abstract][Full Text] [Related]
8. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
9. PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5.
Sen S; He Z; Ghosh S; Dery KJ; Yang L; Zhang J; Sun Z
J Immunol; 2018 Jul; 201(2):440-450. PubMed ID: 29794014
[TBL] [Abstract][Full Text] [Related]
10. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
[TBL] [Abstract][Full Text] [Related]
11. Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology.
van Hamburg JP; de Bruijn MJ; Ribeiro de Almeida C; van Zwam M; van Meurs M; de Haas E; Boon L; Samsom JN; Hendriks RW
Eur J Immunol; 2008 Sep; 38(9):2573-86. PubMed ID: 18792410
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
[TBL] [Abstract][Full Text] [Related]
13. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
[TBL] [Abstract][Full Text] [Related]
14. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
15. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist.
Shibata A; Uga K; Sato T; Sagara M; Igaki K; Nakamura Y; Ochida A; Kono M; Shirai J; Yamamoto S; Yamasaki M; Tsuchimori N
Biochem Pharmacol; 2018 Apr; 150():35-45. PubMed ID: 29369782
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional coactivator TAZ regulates reciprocal differentiation of T
Geng J; Yu S; Zhao H; Sun X; Li X; Wang P; Xiong X; Hong L; Xie C; Gao J; Shi Y; Peng J; Johnson RL; Xiao N; Lu L; Han J; Zhou D; Chen L
Nat Immunol; 2017 Jul; 18(7):800-812. PubMed ID: 28504697
[TBL] [Abstract][Full Text] [Related]
19. Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing RORγt Activity and Suppressing Th17 Cell Differentiation.
Ding Q; Zhao M; Yu B; Bai C; Huang Z
PLoS One; 2015; 10(9):e0137711. PubMed ID: 26368822
[TBL] [Abstract][Full Text] [Related]
20. Eriodictyol suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis.
Yang T; Li X; Yu J; Deng X; Shen PX; Jiang YB; Zhu L; Wang ZZ; Zhang Y
Food Funct; 2020 Aug; 11(8):6875-6888. PubMed ID: 32686813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
